4 Insights on decentralized trials for biotechs
The COVID-19 pandemic accelerated the adoption of decentralized clinical trials (DCTs) by biopharma companies. The clinician-patient relationship will always be key to clinical trials, but decentralized aspects such as direct-to-patient shipments and telehealth are here to stay. Here are four things we have learned about DCTs that biotech companies can consider when designing a decentralized or hybrid trial.
Related Insights
CTB Blog
Modernizing data operations to enable today's Phase 1 trials
Jul 1, 2026
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
CTB Blog
Engage early, design once: turning early-phase trials into a program strategy
Sep 10, 2026
CTB Blog
Five Practical Strategies for Accelerating Early Phase Studies
Aug 19, 2026
Article
Reading current FDA and NMPA trends: What oncology tells us about the changing regulatory landscape
Jul 21, 2026
CTB Blog
In early phase trials, operations is where speed is won or lost
Jun 28, 2026
Related Insights
CTB Blog
Modernizing data operations to enable today's Phase 1 trials
Jul 1, 2026
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
CTB Blog
Engage early, design once: turning early-phase trials into a program strategy
Sep 10, 2026
CTB Blog
Five Practical Strategies for Accelerating Early Phase Studies
Aug 19, 2026
Article
Reading current FDA and NMPA trends: What oncology tells us about the changing regulatory landscape
Jul 21, 2026
CTB Blog
In early phase trials, operations is where speed is won or lost
Jun 28, 2026